Expense Ratio Rating
6 /10
Expense Rating
0 /10
Market Score
9 /10
Category Score
5 /10
Market Size
9 /10
$MACSX Alternatives
Different Funds
We found 10,038 International Stocks Asia/Pacific ex-Japan Stock funds. Here they are ordered by FI Score.
- ryiyx
- Mutual Fund
- Alternative
- Inverse
Rydex Inverse High Yield Strategy Fund Class C
Expenses: 2.35% (Better than 0% of similar funds)
This is a bad choice for a Inverse Alternative fund. See why »
- ryrox
- Mutual Fund
- US Stocks
- Small Blend
Rydex Russell 2000 Fund Class C
Expenses: 2.46% (Better than 0% of similar funds)
This is a bad choice for a Small Blend US Stocks fund. See why »
- pfacx
- Mutual Fund
- US Stocks
- Small Blend
Pacific Funds Small-Cap Class C
Expenses: 1.98% (Better than 0% of similar funds)
This is a bad choice for a Small Blend US Stocks fund. See why »
- trifx
- Mutual Fund
- Allocation
- All-In-One
Catalyst/SMH Total Return Income Fund Class A
Expenses: 1.57% (Better than 0% of similar funds)
This is a bad choice for a All-In-One Allocation fund. See why »
- pfdpx
- Mutual Fund
- Allocation
- Total World
RiskPro® Dynamic 15-25 Fund Class R
Expenses: 2.03% (Better than 0% of similar funds)
This is a bad choice for a Total World Allocation fund. See why »
- esacx
- Mutual Fund
- Alternative
- Short
Wells Fargo Adjustable Rate Government Fund - Class C
Expenses: 1.49% (Better than 0% of similar funds)
This is a bad choice for a Short Alternative fund. See why »
- tpdcx
- Mutual Fund
- Allocation
- All-In-One
Timothy Plan Defensive Strategies Fund Class C
Expenses: 2.16% (Better than 0% of similar funds)
This is a bad choice for a All-In-One Allocation fund. See why »
- rymkx
- Mutual Fund
- Alternative
- Leveraged Equities
Rydex Russell 2000 1.5x Strategy Fund Class H
Expenses: 1.80% (Better than 0% of similar funds)
This is a bad choice for a Leveraged Equities Alternative fund. See why »
- lhcax
- Mutual Fund
- Sector Equity
- Healthcare
Lord Abbett Health Care Fund Class A
Expenses: 1.03% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »